rxstatShortages › Omalizumab

Omalizumab (Xolair) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Aug 31, 2026

Omalizumab has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
3

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

To be discontinued
XOLAIR
300MG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02545160
Avoided
XOLAIR
150MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02260565 · ended Jun 3, 2024 · Delay in shipping of the drug.
Resolved
XOLAIR
150MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02260565 · ended Apr 9, 2024 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Omalizumab. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Omalizumab is classified under “OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES” (ATC R03DX).

Recent changes

Common questions

When will Omalizumab be back in stock in Canada?

Omalizumab has no active shortage; supply is normal per Health Canada reports.

Why is Omalizumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other systemic drugs for obstructive airway diseases)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.